BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38461779)

  • 1. Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan.
    Jhuang JR; Lee CH; Chiang CJ; Chen CJ; Lee WC
    Environ Int; 2024 Mar; 185():108542. PubMed ID: 38461779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy.
    Hsu LI; Chen GS; Lee CH; Yang TY; Chen YH; Wang YH; Hsueh YM; Chiou HY; Wu MM; Chen CJ
    Am J Epidemiol; 2013 Feb; 177(3):202-12. PubMed ID: 23299695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between arsenic-containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan.
    Cheng PS; Weng SF; Chiang CH; Lai FJ
    J Dermatol; 2016 Feb; 43(2):181-6. PubMed ID: 26283637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
    Chiou HY; Chiou ST; Hsu YH; Chou YL; Tseng CH; Wei ML; Chen CJ
    Am J Epidemiol; 2001 Mar; 153(5):411-8. PubMed ID: 11226969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers.
    Chen CJ; Chuang YC; Lin TM; Wu HY
    Cancer Res; 1985 Nov; 45(11 Pt 2):5895-9. PubMed ID: 4053060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer mortality reduction after installation of a tap-water supply system in an arsenious-endemic area in southwestern Taiwan.
    Yang CY; Chiu HF; Chang CC; Ho SC; Wu TN
    Environ Res; 2005 May; 98(1):127-32. PubMed ID: 15721893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area.
    Chang CW; Ou CH; Yu CC; Lo CW; Tsai CY; Cheng PY; Chen YT; Huang HC; Wu CC; Li CC; Lee HY
    BMC Cancer; 2021 Jan; 21(1):80. PubMed ID: 33468084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subsequent risk of internal cancer with Bowen's disease. A population-based study.
    Chute CG; Chuang TY; Bergstralh EJ; Su WP
    JAMA; 1991 Aug; 266(6):816-9. PubMed ID: 1865520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer mortality trends in a blackfoot disease endemic community of Taiwan following water source replacement.
    Tsai SM; Wang TN; Ko YC
    J Toxicol Environ Health A; 1998 Nov; 55(6):389-404. PubMed ID: 9833970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan.
    Yang MH; Chen KK; Yen CC; Wang WS; Chang YH; Huang WJ; Fan FS; Chiou TJ; Liu JH; Chen PM
    Urology; 2002 May; 59(5):681-7. PubMed ID: 11992840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health hazards and mitigation of chronic poisoning from arsenic in drinking water: Taiwan experiences.
    Chen CJ
    Rev Environ Health; 2014; 29(1-2):13-9. PubMed ID: 24552958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type specificity of lung cancer associated with arsenic ingestion.
    Guo HR; Wang NS; Hu H; Monson RR
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):638-43. PubMed ID: 15066930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
    Chen CH; Chiou HY; Hsueh YM; Chen CJ; Yu HJ; Pu YS
    J Urol; 2009 Feb; 181(2):547-52; discussion 553. PubMed ID: 19084863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of exposure assessment to analysis of cancer risk from inorganic arsenic in drinking water in Taiwan.
    Brown KG; Chen CJ
    Risk Anal; 1995 Aug; 15(4):475-84. PubMed ID: 7480947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple primary cancers in blackfoot endemic area: report of a case].
    Chen KS; Huang CC; Liaw CC; Chen TJ
    Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1125-8. PubMed ID: 2853200
    [No Abstract]   [Full Text] [Related]  

  • 18. [Expression of keratin 16 in normal and lesional skin of solitary and multiple Bowen's disease using monoclonal antibody Ks 8.12 staining].
    Sheu HM; Ko SS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1252-5. PubMed ID: 1724782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of heme oxygenase-1 gene promoter polymorphism on cancer risk by histological subtype: A prospective study in arseniasis-endemic areas in Taiwan.
    Wu MM; Lee CH; Hsu LI; Cheng WF; Lee TC; Wang YH; Chiou HY; Chen CJ
    Int J Cancer; 2016 Apr; 138(8):1875-86. PubMed ID: 26566708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bowen's diseases and basal cell carcinomas in a patient.
    Kim HJ; Min HG; Lee ES
    J Dermatol; 1999 Oct; 26(10):695-7. PubMed ID: 10554439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.